Verification of the usefulness of per-oral esophageal muscle biopsy for esophageal motility disorders

Verification of the usefulness of per-oral esophageal muscle biopsy for esophageal motility disorders - The usefulness of per-oral esophageal muscle biopsy for esophageal motility disorders

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040256

Enrollment

100

Registered

2020-04-27

Start date

2020-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal motility disorders

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed with esophageal motility disorders 2) Performance status(ECOG): 0-1 3) Written informed consent is obtained from patients.

Exclusion criteria

Exclusion criteria: 1) Patients with bleeding tendency (Platelet<50,000/mm3 or PT-INR>2 without anticoagulant) 2) Patients with liver dysfunction (Child-Pugh score: B-C) 3) Patients with chronic renal failure on hemodialysis

Design outcomes

Primary

Measure	Time frame
The eosinophil infiltration in the esophageal muscle layer	—

Countries

Japan

Contacts

Public ContactOsamu Goto

Nippon Medical School Department of Gastroenterology

o-goto@nms.ac.jp03-3822-2131

Outcome results